On the forefront of healthcare change, turning innovative science into value for patients: Astellas at ASCO 2025

At this year’s American Society of Clinical Oncology Annual Meeting, web editor Nicole Raleigh sat down with Claus Zieler, chief commercial and medical affairs officer & member of the Executive Committee at Astellas Pharma.

The conversation explores the 16 abstracts presented by Astellas at the Congress, including new data across approved cancer therapies for patients with prostate, urothelial, and gastric/gastroesophageal junction (GEJ) cancers.

Zieler also discusses the customer engagement and clinical outcomes that matter to patients, his own role now in shaping Medical Affairs at Astellas, and insights from the Congress more generally.

Watch this and other conversations from ASCO 2025 here.